Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ascendis Health's Enterprise Value is R485 Mil.
Ascendis Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was R-239 Mil. Therefore, Ascendis Health's EV-to-EBIT ratio for today is -2.03.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ascendis Health's Enterprise Value is R485 Mil.
Ascendis Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was R-239 Mil. Therefore, Ascendis Health's EV-to-EBITDA ratio for today is -2.03.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ascendis Health's Enterprise Value is R485 Mil.
Ascendis Health's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was R1,535 Mil. Therefore, Ascendis Health's EV-to-Revenue ratio for today is 0.32.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Ascendis Health's Enterprise Value is R485 Mil.
Ascendis Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was R-176 Mil. Therefore, Ascendis Health's EV-to-FCF ratio for today is -2.75.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Ascendis Health (JSE:ASC) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ascendis Health's current Enterprise Value is R485 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ascendis Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was R-239 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ascendis Health's current Enterprise Value is R485 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ascendis Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was R-239 Mil.
Ascendis Health's current Enterprise Value is R485 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ascendis Health's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was R1,535 Mil.
Ascendis Health's current Enterprise Value is R485 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ascendis Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2023 was R-140 Mil.
Ascendis Health's current Enterprise Value is R485 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ascendis Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was R-176 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Health Enterprise Value Related Terms
Ascendis Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for Ascendis Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ASC vs PHBI, GCAN, SGBI: Enterprise Value Comparison
For the Medical Distribution subindustry, Ascendis Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascendis Health Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ascendis Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ascendis Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ascendis Health's Enterprise Value for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Health (JSE:ASC) has a Enterprise Value of R485 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ascendis Health and its competitors.
Is Ascendis Health's Enterprise Value too high?
Ascendis Health's current Enterprise Value is R485 Mil. Overall, Ascendis Health has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Health's Enterprise Value compare to PHBI and GCAN?
Ascendis Health's Enterprise Value of R485 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ascendis Health and its competitors. Ascendis Health's current Enterprise Value is R485 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Health stock overvalued right now?
Ascendis Health (JSE:ASC) has a current Enterprise Value of R485 Mil. The current Enterprise Value is R485 Mil. Ascendis Health's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Ascendis Health (JSE:ASC), the current Enterprise Value is R485 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ascendis Health Ltd is a health and wellness investment holding Company that holds investments in a number of companies that market and distribute a portfolio of brands, products, and medical devices. The company operates in two segments: i) Consumer Health (wellness, health supplements, speciality ingredients and compounded medicines) and ii) Medical Devices (distributor of medical devices, in vitro diagnostic products and orthopaedic equipment). The company generates the majority of its revenue from the Medical Devices segment.
11GF Score
Get the complete analysis for JSE:ASC
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ASC has been successfully added to your 
